The global atopic dermatitis market size was valued at USD 6.62 billion in 2025 and is predicted to hit around USD 12.97 billion by 2034, rising at a 7.75% CAGR, a study published by Towards ...
Atopic dermatitis (AD) is a chronic disease that affects an increasing number of children and adults. The skin is dry and ...
Amgen ends its rocatinlimab partnership, returning control to Kyowa Kirin, citing strategy changes, weaker Phase 3 results ...
A recent study published in JAMA Dermatology has demonstrated that PROMIS measures are valid tools for evaluating the ...
The decision comes more than a year after disappointing initial Phase 3 results and casts further doubt on a class of ...
The product creators say it is designed specifically for compromised and inflamed skin. SOS Serum, which is available from £5, is an oil-free, cooling formula that delivers rapid relief from itching, ...
When COVID hit, health care systems around the world were turned upside down. Hospitals cleared beds, routine appointments ...
Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market ...
Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027Data from the ongoing parallel BROADEN2 Phase 2b atopic ...
As instances of scalp flaking increase and people scratch their heads in shame, dermatologists give some advice ...
Paulina Siembor had struggled with her sensitive skin on her face which flared up regularly ...
To help you find the best eczema-friendly skin care products, I tapped several dermatologists for their insights and product recommendations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results